NWBO

Northwest Biotherapeutics Cross-source read$0.17 0.00%
Health CareCUSIP 66737P600· EOD Sep 11, 2026

Among active 13F managers last quarter, 2 opened and none reduced or exited; the largest holder to move was Compass Financial Management LLC (new position). No open-market insider trades in the last 180 days.

Tracked 13F holders
7
6 in Q2 2026 filings
13F value (tracked)
$403K
Smart-money readBullish
Net sellingNet buying
Funds · active managers, latest 13F
2 adding · 0 trimming
Insiders · Form 4 open-market, 180d
0 buying · 0 selling
US House · STOCK Act, 180d
0 buying · 0 selling

Funds lean in and no leg opposes.

Price & smart-money activity

$0.17 0.00%5Y -86.2%
$0.04$0.46$0.89$1.32$1.75202120222023202420252026232
Hover for who · click for detailEnd-of-day closing prices52w $0.15 – $0.32

Who owns NWBO?

7 tracked 13F filers · ranked by shares held

7 tracked 13F filers disclose a position in NWBO as of the latest SEC 13F filings, a combined $403K in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

#FundSharesPosition valueLast moveAs ofHistory
1Compass Financial Management LLC1.2M
$227K
New
+1.2M sh
Q2 2026
2Kelleher Financial Advisors800K
$149K
+300%
Added · +600K sh
Q2 2026
3VSM Wealth Advisory, LLC81K
$15K
Held
Q2 2026
4Ethos Financial Group, LLC39K
$6K
Held
Q2 2026
5Williams Jones Wealth Management, LLC.25K
$5K
Held
Q2 2026
6Coston, McIsaac & Partners1K
$0
Held
Q2 2026
7McIlrath & Eck, LLC600
$124
New
+600 sh
Q1 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Is NWBO being bought or sold by institutions?

Last quarter, 2 funds opened a new position in NWBO, while none reduced or exited. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).

Opened
2
funds took a first position
Biggest moves · ranked by size of the change, positions above a floor

Funds that own NWBO also own

CompanyCo-held byTheir position there
Apple IncAAPL4 funds$84.0M
Vanguard Growth ETFVUG4 funds$80.2M
Microsoft CorpMSFT4 funds$70.2M
Vanguard Value ETFVTV4 funds$63.5M
Vanguard S&P 500 ETFVOO4 funds$55.8M
Nvidia CorpNVDA4 funds$45.9M
SS SPDR S&P 500 ETF Trust-USSPY4 funds$41.3M
Vanguard Large-Cap ETFVV4 funds$40.3M
Vanguard Tot World STK ETFVT4 funds$38.3M
Berkshire Hathaway Inc-CL BBRK/B4 funds$35.5M
Vanguard Dividend Apprec ETFVIG4 funds$35.3M
Invesco QQQ Trust Series 1QQQ4 funds$34.2M

Ranked by how many of NWBO's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in NWBO.

Insider activity (Form 4)

Full insider page →
Net · 180d
$0
0 open-market transactions
DateInsiderRoleActionSharesValue
Nov 17, 2023Malik NavidDirectorBuy (S)
2 lots, same day
445K$365K
Nov 16, 2023Malik NavidDirectorBuy (S)125K$105K
Dec 28, 2018Powers Linda FPresident and CEO, Director, 10% OwnerSell (S)804K$137K
Dec 27, 2018Powers Linda FPresident and CEO, Director, 10% OwnerSell (S)3.6M$605K
Jun 30, 2015Cognate Bioservices, Inc.10% OwnerSell (S)
2 lots, same day
1.8M$7.3M
Sep 15, 2014Toucan General II, LLC10% OwnerSell (S)150K$751K
Sep 1, 2014Toucan General II, LLC10% OwnerBuy (P)639K
Aug 27, 2014Toucan General II, LLC10% OwnerSell (S)145K$750K
Aug 1, 2014Toucan General II, LLC10% OwnerBuy (P)550K
Aug 1, 2014Farmer Robert ADirectorBuy (P)3K$17K
Jul 1, 2014Toucan General II, LLC10% OwnerBuy (P)797K
Jun 30, 2014Toucan General II, LLC10% OwnerBuy (P)563K

One row per insider, day and transaction code; shares and value are summed across the lots. Every lot is on the full insider page and in the filing.

Do institutions, insiders and Congress agree?

Mixed signals

Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.

SEC EDGAR 13F + Form 4 + US House STOCK Act{ }get_ticker_confluence · API & MCP

Signals by source

Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive

SourceBuyingSellingNet
13F funds
Top 100 holders by value, passive included; the hero counts active managers only
10
Insiders
Form 4 open-market
00$0
US House
STOCK Act trades
00$0
Sector rotation
NWBO is in Health Care, which smart money is rotating OUT OF
$5.0B

Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.

Institutional ownership over time

6 tracked filers in Q2 2026 filings+0 vs Q1 2026
036Q3 2024Q1 2025Q3 2025Q1 2026Q2 2026
tracked filers holding their reported valueQ2 2026 filings: $403K
Each bar counts tracked filers with a position in that quarter's filings, so the newest bar excludes filers still on an earlier quarter. Arkolith's tracked universe has grown over this window; part of any long-run rise is coverage, not new buyers.

Recent filings

15 most recent

Keep exploring

Connected entities for NWBO

Browse more

Build

Ask your agent what changed in NWBO

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/NWBO/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for NWBO.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for NWBO. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.